Viromed Medical AG Secures Turkish Registration for ViroCAP®

Viromed Medical AG has successfully obtained registration for its ViroCAP® device in Turkey's ÜTS product tracking system. This cold plasma medical technology is now ready for marketing and distribution, overcoming earlier certification delays. The registration aligns with Viromed’s international expansion strategy, allowing the company to enter a significant growth market.

With the ÜTS approval, ViroCAP® is officially recorded in the Turkish medical system, supporting patient care with its innovative contact-free plasma application. The compact device operates independently of external gas supplies, providing flexibility in various medical settings. This breakthrough enables Viromed to fulfill substantial existing Turkish orders, totaling approximately 2,000 units. CEO Uwe Perbandt emphasized the milestone’s importance for market development, facilitated by collaboration with Turkish partners.